Nanoscope Publishes Breakthrough Showing MCO-010 Treatment Arrests Neurodegeneration

DALLAS, Oct. 21, 2024 /PRNewswire/ -- Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative diseases today announced a breakthrough discovery in Translational Vision Science & Technology (TVST, an ARVO journal)...